Abstract
Purpose
Selenium, incorporated into specific seleno-enzymes, is essential to proper thyroid function and protect cells from oxidative damage induced by H2O2 during thyroid hormone synthesis. Several studies indicated that low selenium levels are associated with thyroid autoimmunity and related disorders, but real effectiveness of selenium supplementation in such diseases is still controversial. We evaluated the effect of selenium on oxidative damage in human thyrocytes and thyroid fibroblasts in vitro.
Methods
To induce oxidative stress, primary cultures were exposed to H2O2, in the presence or the absence of selenium, as either selenomethionine or selenite. We performed the following assays: cell viability, caspase-3 activity, BCL-2/BAX gene expression, DNA fragmentation, malondialdehyde levels, and glutathione peroxidase (GPx) activity measurements.
Results
Thyrocytes and thyroid fibroblasts exposed to H2O2 and preincubated with both selenocompounds displayed a significant dose-dependent increase in cell viability compared to cells incubated with H2O2 alone. Pretreatment with selenomethionine and selenite significantly reduced caspase-3 activity and BAX mRNA levels and increased BCL-2 mRNA levels in a dose-dependent manner. Accordingly, H2O2 induced a diffuse pattern of DNA degradation and an increase in malondialdehyde levels, which was prevented by the pretreatment with both selenomethionine and selenite. Both selenocompounds induced an increase in GPx activity, suggesting that these protective effects may be, almost in part, mediated by these selenoproteins.
Conclusion
In human thyrocytes and fibroblasts in vitro, selenium exerts protective effects against H2O2 in a dose-dependent manner, being selenite effective at lower doses than selenomethionine.
Similar content being viewed by others
References
M.P. Rayman, Selenium and human health. Lancet 379, 1256–1268 (2012)
Z. Huang, A.H. Rose, P.R. Hoffmann, The role of selenium in inflammation and immunity: from molecular mechanisms to therapeutic opportunities. Antioxid. Redox Signal. 16, 705–743 (2012)
J.C. Avery, P.R. Hoffmann, Selenium, selenoproteins, and immunity. Nutrients 10, E1203 (2018)
J. Köhrle, Selenium and the thyroid. Curr. Opin. Endocrinol. Diabetes Obes. 22, 392–401 (2015)
G. Di Dalmazi, J. Hirshberg, D. Lyle, J.B. Freij, P. Caturegli, Reactive oxygen species in organ-specific autoimmunity. Auto. Immun. Highlights 7, 11 (2016)
C.L. Burek, N.R. Rose, Autoimmune thyroiditis and ROS. Autoimmun. Rev. 7, 530–537 (2008)
C.L. Burek, M.V. Talor, Environmental triggers of autoimmune thyroiditis. J. Autoimmun. 33, 183–189 (2009)
R. Sharma, K. Traore, M.A. Trush, N.R. Rose, C. Burek, Intracellular adhesion molecule-1 up-regulation on thyrocytes by iodine of non-obese diabetic. H2(h4) mice is reactive oxygen species-dependent. Clin. Exp. Immunol. 152, 13–20 (2008)
M. Zarkovi, The role of oxidative stress on the pathogenesis of graves’ disease. J. Thyroid. Res. 2012, 302537 (2012)
G. Effraimidis, W.M. Wiersinga, Mechanisms in endocrinology: autoimmune thyroid disease: old and new players. Eur. J. Endocrinol. 170, 241–252 (2014)
I. Ates, F.M. Yilmaz, M. Altay, N. Yilmaz, D. Berker, S. Güler, The relationship between oxidative stress and autoimmunity in Hashimoto’s thyroiditis. Eur. J. Endocrinol. 173, 791–799 (2015)
R.M. Ruggeri, T.M. Vicchio, M. Cristani, R. Certo, D. Caccamo, A. Alibrandi, S. Giovinazzo, A. Saija, A. Campennì, F. Trimarchi, S. Gangemi, Oxidative stress and advanced glycation end products in Hashimoto’s thyroiditis. Thyroid 26, 504–511 (2016)
R.M. Ruggeri, M. Cristani, T.M. Vicchio, A. Alibrandi, S. Giovinazzo, A. Saija, A. Campennì, F. Trimarchi, S. Gangemi, Increased serum interleukin-37 (IL-37) levels correlate with oxidative stress parameters in Hashimoto’s thyroiditis. J. Endocrinol. Investig. 2, 199–205 (2018)
M. Kucharzewski, J. Braziewicz, U. Majewska, S. Góźdź, Concentration of selenium in the whole blood and the thyroid tissue of patients with various thyroid diseases. Biol. Trace Elem. Res. 88, 25–30 (2002)
H. Derumeaux, P. Valeix, K. Castetbon, M. Bensimon, M.C. Boutron-Ruault, J. Arnaud, S. Hercberg, Association of selenium with thyroid volume and echostructure in 35- to 60-year-old French adults. Eur. J. Endocrinol. 148, 309–315 (2003)
T. Wertenbruch, H.S. Willenberg, C. Sagert, T.B. Nguyen, M. Bahlo, J. Feldkamp, C. Groeger, D. Hermsen, W.A. Scherbaum, M. Schott, Serum selenium levels in patients with remission and relapse of Graves' disease. J. Med. Chem. 3, 281–284 (2007)
L.B. Rasmussen, L. Schomburg, J. Köhrle, I.B. Pedersen, B. Hollenbach, A. Hög, L. Ovesen, H. Perrild, P. Laurberg, Selenium status, thyroid volume, and multiple nodule formation in an area with mild iodine deficiency. Eur. J. Endocrinol. 164, 585–590 (2011)
Q. Wu, M.P. Rayman, H. Lv, L. Schomburg, B. Cui, C. Gao, P. Chen, G. Zhuang, Z. Zhang, X. Peng, H. Li, Y. Zhao, X. He, G. Zeng, F. Qin, P. Hou, B. Shi, Low population selenium status is associated with increased prevalence of thyroid disease. J. Clin. Endocrinol. Metab. 100, 4037–4047 (2015)
Y. Liu, S. Liu, J. Mao, S. Piao, J. Qin, S. Peng, X. Xie, H. Guan, Y. Li, Z. Shan, W. Teng, Serum trace elements profile in graves’ disease patients with or without orbitopathy in Northeast China. Biomed. Res. Int. 2018, 3029379 (2018)
L.H. Duntas, The role of iodine and selenium in autoimmune thyroiditis. Horm. Metab. Res. 47, 721–726 (2015)
S. Hu, M.P. Rayman, Multiple nutritional factors and the risk of Hashimoto's thyroiditis. Thyroid 27, 597–610 (2017)
M.P. Rayman, Multiple nutritional factors and thyroid disease, with particular reference to autoimmune thyroid disease. Proc. Nutr. Soc. 78, 34–44 (2019)
A. Drutel, F. Archambeaud, P. Caron, Selenium and the thyroid gland: more good news for clinicians. Clin. Endocrinol. 78, 155–164 (2013)
F. Karimi, G.R. Omrani, Effects of selenium and vitamin C on the serum level of antithyroid peroxidase antibody in patients with autoimmune thyroiditis. J. Endocrinol. Investig. 4, 481–487 (2018)
J. Wichman, K.H. Winther, S.J. Bonnema, L. Hegedus, Selenium supplementation significantly reduces thyroid autoantibody levels in patients with chronic autoimmune thyroiditis: a systematic review and meta-analysis. Thyroid 26, 1681–1692 (2016)
K.H. Winther, J.E. Wichman, S.J. Bonnema, L. Hegedous, Insufficient documentation for clinical efficacy of selenium supplementation in chronic autoimmune thyroiditis, based on a systematic review and meta-analysis. Endocrine 55, 376–385 (2017)
G. Rotondo Dottore, M. Leo, G. Casini, F. Latrofa, L. Cestari, S. Sellari-Franceschini, M. Nardi, P. Vitti, C. Marcocci, M. Marinò, Antioxidant actions of selenium in orbital fibroblasts: a basis for the effects of selenium in Graves’ orbitopathy. Thyroid 27, 271–278 (2017)
G. Rotondo Dottore, I. Ionni, F. Menconi, G. Casini, S. Sellari-Franceschini, M. Nardi, P. Vitti, C. Marcocci, M. Marinò, Antioxidant effects of β-carotene, but not of retinol and vitamin E, in orbital fibroblasts from patients with Graves’ orbitopathy (GO). J. Endocrinol. Investig. 41, 815–820 (2018)
G. Rotondo Dottore, I. Ionni, F. Menconi, G. Casini, S. Sellari-Franceschini, M. Nardi, P. Vitti, C. Marcocci, M. Marinò, Action of three bioavailable antioxidants in orbital fibroblasts from patients with Graves’ orbitopathy (GO): a new frontier for GO treatment? J. Endocrinol. Investig. 41, 193–201 (2018)
M.M. Bradford, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 7, 248–254 (1976)
Y. Saito, K. Nishio, Y. Ogawa, J. Kimata, T. Kinumi, Y. Yoshida, N. Noguchi, E. Niki, Turning point in apoptosis/necrosis induced by hydrogen peroxide. Free. Radic. Res. 40, 619–630 (2006)
Y. Song, N. Driessens, M. Costa, X. De Deken, V. Detours, B. Corvilain, C. Maenhaut, F. Miot, J. Van Sande, M.C. Many, J.E. Dumont, Roles of hydrogen peroxide in thyroid physiology and disease. J. Clin. Endocrinol. Metab. 92, 3764–3773 (2007)
C. Ghaddhab, A. Kyrilli, N. Driessens, E. Van Den Eeckhaute, O. Hancisse, X. De Deken, J.E. Dumont, V. Detours, F. Miot, B. Corvilain, Factors contributing to the resistance of the thyrocyte to hydrogen peroxide. Mol. Cell. Endocrinol. 481, 62–70 (2019)
B. Contempre, O. Le Moine, J.E. Dumont, J.F. Denef, M.C. Many, Selenium deficiency and thyroid fibrosis. A key role for macrophages and transforming growth factor beta (TGF-beta). Mol. Cell. Endocrinol. 124, 7–15 (1996)
H. Xue, W. Wang, Y. Li, Z. Shan, Y. Li, X. Teng, Y. Gao, C. Fan, W. Teng, Selenium upregulates CD4(+) CD25(+) regulatory T cells in iodine-induced autoimmune thyroiditis model of NOD.H-2(h4) mice. Endocr. J. 57, 595–601 (2010)
W. Wang, H. Xue, Y. Li, X. Hou, C. Fan, H. Wang, H. Zhang, Z. Shan, W. Teng, Effects of selenium supplementation on spontaneous autoimmune thyroiditis in NOD.H-2h4 mice. Thyroid 25, 1137–1144 (2015)
A. Demelash, J.O. Karlsson, M. Nilsson, U. Bjorkman, Selenium has a protective role in caspase-3-dependent apoptosis induced by H2O2 in primary cultured pig thyrocytes. Eur. J. Endocrinol. 150, 841–849 (2004)
P. Lehmann, P. Rank, K.L. Hallfeldt, B. Krebs, R. Gärtner, Dose-related influence of Na2SO3 on apoptosis in human thyroid follicles in vitro induced by iodine, EGF, TGF-beta, and H2O2. Biol. Trace Elem. Res. 112, 119–130 (2006)
L. Tan, W. Sun, Z.N. Sang, W.Q. Zhang, The effect of selenium on the expression of Fas/FasL in experimental autoimmune thyroiditis rats’ thyroid with adequate iodine. Zhonghua. Yu. Fang. Yi. Xue. Za. Zhi. 42, 640–643 (2008)
I. Nettore, E. De Nisco, S. Desiderio, C. Passaro, L. Maione, M. Negri, L. Albano, R. Pivonello, C. Pivonello, G. Portella, P. Ungaro, A. Colao, P.E. Macchia, Selenium supplementation modulates apoptotic processes in thyroid follicular cells. Biofactors 43, 415–423 (2017)
J. Chiu-Ugalde, E.K. Wirth, M.O. Klein, R. Sapin, N. Fradejas-Villar, K. Renko, L. Schomburg, J. Köhrle, U. Schweizer, Thyroid function is maintained despite increased oxidative stress in mice lacking selenoprotein biosynthesis in thyroid epithelial cells. Antioxid. Redox Signal. 6, 902–913 (2012)
C. Di Dato, D. Gianfrilli, E. Greco, M. Astolfi, S. Canepari, A. Lenzi, A.M. Isidori, E. Giannetta, Profiling of selenium absorption and accumulation in healthy subjects after prolonged L-selenomethionine supplementation. J. Endocrinol. Investig. 40, 1183–1190 (2017)
G. Mantovani, A.M. Isidori, C. Moretti, C. Di Dato, E. Greco, P. Ciolli., M. Bonomi, L. Petrone, A. Fumarola, G. Campagna, G. Vannucchi, S. Di Sante, C. Pozza, A. Faggiano, A. Lenzi, E. Giannetta, Selenium supplementation in the management of thyroid autoimmunity during pregnancy: results of the “SERENA study”, a randomized, double-blind, placebo-controlled trial. Endocrine (2019). https://doi.org/10.1007/s12020-019-01958-1
R.F. Burk, B.K. Norsworthy, K.E. Hill, A.K. Motley, D.W. Byrne, Effects of chemical form of selenium on plasma biomarkers in a high-dose human supplementation trial. Cancer Epidemiol. Biomark. Prev. 15, 804–810 (2006)
C.D. Thomson, C.E. Burton, M.F. Robinson, On supplementing the selenium intake of New Zealanders. 1. Short experiments with large doses of selenite or selenomethionine. Br. J. Nutr. 39, 579–587 (1978)
S.J. Fairweather-Tait, R. Collings, R. Hurst, Selenium bioavailability: current knowledge and future research requirements. Am. J. Clin. Nutr. 91, 1484–1491 (2010)
M. Roman, P. Jitaru, C. Barbante, Selenium biochemistry and its role for human health. Metallomics 6, 25–54 (2014)
R. Robinson, M.E. Robinson, O.A. Levander, C.D. Thomson, Urinary excretion of selenium by New Zealand and North American human subjects on differing intakes. Am. J. Clin. Nutr. 41, 1023–1031 (1985)
G. Alfthan, A. Aro, H. Arvilommi, J.K. Huttunen, Selenium metabolism and platelet glutathione peroxidase activity in healthy Finnish men: effects of selenium yeast, selenite, and selenate. Am. J. Clin. Nutr. 53, 120–125 (1991)
Author contribution
Each author gave a substantial contribute to the paper and approved the final version to be published.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Informed consent
was obtained from patients. The study was approved by the local Ethical Committee.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
About this article
Cite this article
Ruggeri, R.M., D’Ascola, A., Vicchio, T.M. et al. Selenium exerts protective effects against oxidative stress and cell damage in human thyrocytes and fibroblasts. Endocrine 68, 151–162 (2020). https://doi.org/10.1007/s12020-019-02171-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-019-02171-w